Correlation Between DiaMedica Therapeutics and Oculis Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Oculis Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Oculis Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Oculis Holding AG, you can compare the effects of market volatilities on DiaMedica Therapeutics and Oculis Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Oculis Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Oculis Holding.

Diversification Opportunities for DiaMedica Therapeutics and Oculis Holding

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between DiaMedica and Oculis is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Oculis Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oculis Holding AG and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Oculis Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oculis Holding AG has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Oculis Holding go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Oculis Holding

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.44 times more return on investment than Oculis Holding. However, DiaMedica Therapeutics is 2.26 times less risky than Oculis Holding. It trades about -0.42 of its potential returns per unit of risk. Oculis Holding AG is currently generating about -0.29 per unit of risk. If you would invest  577.00  in DiaMedica Therapeutics on January 13, 2025 and sell it today you would lose (230.00) from holding DiaMedica Therapeutics or give up 39.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy68.18%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  Oculis Holding AG

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days DiaMedica Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Oculis Holding AG 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Oculis Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in May 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

DiaMedica Therapeutics and Oculis Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and Oculis Holding

The main advantage of trading using opposite DiaMedica Therapeutics and Oculis Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Oculis Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oculis Holding will offset losses from the drop in Oculis Holding's long position.
The idea behind DiaMedica Therapeutics and Oculis Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios